1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
51.62%
Revenue growth above 1.5x 6617.T's 21.25%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
17.58%
Gross profit growth at 50-75% of 6617.T's 34.48%. Martin Whitman would question if cost structure or brand is lagging.
170.34%
EBIT growth below 50% of 6617.T's 401.44%. Michael Burry would suspect deeper competitive or cost structure issues.
99.60%
Operating income growth under 50% of 6617.T's 401.44%. Michael Burry would be concerned about deeper cost or sales issues.
579.76%
Net income growth above 1.5x 6617.T's 200.60%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
577.93%
EPS growth above 1.5x 6617.T's 200.68%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
581.13%
Diluted EPS growth above 1.5x 6617.T's 200.68%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
0.03%
Slight or no buyback while 6617.T is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.63%
10Y CAGR of 30.63% while 6617.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
80.38%
Positive 5Y CAGR while 6617.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
35.16%
3Y revenue/share CAGR above 1.5x 6617.T's 4.75%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.87%
10Y net income/share CAGR of 24.87% while 6617.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
149.22%
5Y net income/share CAGR above 1.5x 6617.T's 36.65%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
2161.73%
3Y net income/share CAGR above 1.5x 6617.T's 322.04%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
407.24%
10Y equity/share CAGR above 1.5x 6617.T's 8.06%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
61.13%
5Y equity/share CAGR above 1.5x 6617.T's 8.08%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
31.31%
3Y equity/share CAGR above 1.5x 6617.T's 8.14%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.10%
AR growth well above 6617.T's 13.19%. Michael Burry fears inflated revenue or higher default risk in the near future.
-9.50%
Inventory is declining while 6617.T stands at 3.02%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
6.44%
Asset growth above 1.5x 6617.T's 1.41%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.19%
BV/share growth above 1.5x 6617.T's 2.12%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
19.79%
We have some new debt while 6617.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
13.85%
We increase R&D while 6617.T cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
8.26%
SG&A growth well above 6617.T's 1.10%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.